Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
BIOSYNTH AG currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio is distributed across 2 distinct examiners and 2 distinct art units. Such a distribution suggests that the company is navigating multiple regulatory pathways simultaneously, as each pending action is handled by a different examiner in a separate art unit.
The busiest examiner for this portfolio is MCINTOSH III, TRAVISS C, who is responsible for 1 pending office action. Because the total count of pending office actions is 2 and the busiest examiner handles 1, the workload is split among the 2 distinct examiners involved. Practitioners should note that the 2 distinct art units may apply different examination standards even within the same Biotechnology & Pharmaceuticals field.
The presence of 2 pending office actions across multiple units requires a prosecution strategy that accounts for the specific nuances of each administrative group. MCINTOSH III, TRAVISS C represents a portion of the company's current interaction with the patent office. The data reflects a focused but divided administrative footprint for BIOSYNTH AG.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
| MCINTOSH III, TRAVISS C | 1 | 73.2% | +14.0% |
| WHITE, ASHLEY TAYLOR | 1 | 25.0% | +46.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17908886 | LUCIFERASE-BASED METHODS FOR DETECTING BACTERIAL AND FUNGAL CELLS AND ASSESSING SUSCEPTIBILITY OF BACTERIAL CELLS TO ANTIBIOTICS | WHITE, ASHLEY TAYLOR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041682 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | RODRIGUEZ, RAYNA B | 5d overdue |
| 18271401 | METHOD OF MAKING NICOTINAMIDE RIBOFURANOSIDE SALTS BY SALT METATHESIS, THE CRYSTALLINE FORM OF ITS TOSYLATE SALT AND THE CO-CRYSTALLIZED FORM OF ITS CHLORIDE:IODIDE SALT | MCINTOSH III, TRAVISS C | — |
| 17908886 | LUCIFERASE-BASED METHODS FOR DETECTING BACTERIAL AND FUNGAL CELLS AND ASSESSING SUSCEPTIBILITY OF BACTERIAL CELLS TO ANTIBIOTICS | WHITE, ASHLEY TAYLOR | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1693 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18041682 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | RODRIGUEZ, RAYNA B | 1628 | §112 | Non-Final OA | 5d overdue | Pending | Oct 27, 2023 |
| 18271401 | METHOD OF MAKING NICOTINAMIDE RIBOFURANOSIDE SALTS BY SALT METATHESIS, THE CRYSTALLINE FORM OF ITS TOSYLATE SALT AND THE CO-CRYSTALLIZED FORM OF ITS CHLORIDE:IODIDE SALT | MCINTOSH III, TRAVISS C | 1693 | §112 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 17908886 | LUCIFERASE-BASED METHODS FOR DETECTING BACTERIAL AND FUNGAL CELLS AND ASSESSING SUSCEPTIBILITY OF BACTERIAL CELLS TO ANTIBIOTICS | WHITE, ASHLEY TAYLOR | 1653 | §103 | Non-Final OA | — | Pending | Sep 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial